Drug Topics
JULY 23, 2024
A survey conducted by Surescripts, a health care solutions company, explored the attitudes of pharmacists and prescribers towards ongoing issues and challenges currently facing the industry.
Pharmacy Is Right For Me
JULY 23, 2024
Hey there, future pharmacists! I’m Shelby, a student pharmacist at the University of Findlay (UF), and I’m here to share my journey with you. If you’re thinking about a career in pharmacy or just curious about what it’s like, you’re in the right place! Falling in Love with Findlay My adventure started the summer before my senior year of high school at Findlay’s Summer Pharmacy Camp.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
JULY 23, 2024
MK-1654 (clesrovimab) met its primary efficacy endpoint of incidence of patients with RSV-associated medically attended lower respiratory infections (MALRI) through Day 150.
PharmaVoice
JULY 23, 2024
BARDA director Gary Disbrow explains the agency’s focus, how companies can get their “foot in the door” and why platforms are so important for preparedness.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Drug Topics
JULY 23, 2024
Industry experts explored the increase in US prescription drug spending and how state spending targets come into play regarding patients’ rising out-of-pocket costs.
STAT
JULY 23, 2024
CVS Caremark, one of the largest pharmacy benefit managers in the country, agreed to pay at least $45 million to the state of Illinois to settle allegations that rebates were not passed through during a recent four-year period, according to a document obtained by STAT. At issue is a complicated, behind-the-scenes relationship between the PBM and several related entities — in particular, a so-called group purchasing organization — that allegedly obscured rebates paid by drug manufac
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
STAT
JULY 23, 2024
Following the release of widely touted study results for a Gilead Sciences HIV treatment, a new analysis finds the medicine — called lenacapavir — could be made for as little as $26 to $40 per person each year, which the researchers argue could alleviate concerns about limited access in many countries. The medicine drew considerable attention last month after a late-stage clinical trial found that twice-a-year injections completely protected cisgender women from contracting HIV.
Drug Topics
JULY 23, 2024
In part 1 of a recent conversation on Over the Counter, Mayank Amin, PharmD, RPh, MBA, shared his journey from pharmacy school to pharmacy ownership.
STAT
JULY 23, 2024
Jeffrey Shuren, longtime chief regulator of medical devices at the Food and Drug Administration, announced to staff on Tuesday that he is leaving the agency, according to six sources and an email reviewed by STAT. Shuren, who spent 28 years at the agency, started his FDA career in the Commissioner’s Office in 1998. He became director of the Center for Devices and Radiological Health in 2009 and has served in that position ever since.
Drug Topics
JULY 23, 2024
In part 2 of his interview with Drug Topics featured on Over the Counter, Mayank Amin, PharmD, RPh, MBA, discusses how he redefined the role of a pharmacy at Skippack Pharmacy.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
STAT
JULY 23, 2024
Medicare and Medicaid are facing a familiar quandary: how to provide coverage for new weight loss drugs with price tags that could effectively bankrupt the federal government’s health care budget while simultaneously ensuring continuous coverage for all other health care services used by millions of Americans. The Centers for Medicare and Medicaid Services announced in March 2024 that it would cover Wegovy (semaglutide), a new and expensive weight loss medication, for beneficiaries with c
Pharmacy Times
JULY 23, 2024
A 5:2 intermittent fasting plan combined with meal replacement had better positive outcomes compared with metformin and empagliflozin.
STAT
JULY 23, 2024
Hospitals across the country are facing a severe shortage of supplies of blood culture bottles, critical tools for diagnosing serious and sometimes life-threatening bloodstream infections. The Centers for Disease Control and Prevention sent out an alert Tuesday to health care providers, laboratory professionals, health care facility administrators, and state, tribal, local, and territorial health departments warning of the shortage of Bactec blood culture medium bottles, marketed by Becton Dicki
Fierce Healthcare
JULY 23, 2024
An analysis by Fierce Healthcare identified the top 30 healthcare organizations that burned through the most cash lobbying Congress for healthcare policy changes in the second quarter. | In the second quarter, 14 healthcare organizations spent more than a million dollars lobbying the federal government for healthcare policy change. The leaders of the pack were the American Hospital Association, AARP and the American Medical Association, followed by a slew of payers.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
STAT
JULY 23, 2024
The House Oversight Committee kept pressure on drug middlemen at a hearing today that focused on a new committee report that criticizes industry practices. Pharmacy benefit managers steer patients to PBM-owned pharmacies while underpaying competing pharmacies, according to the report, which highlights concerns that lawmakers have been pounding for years.
Pharmacy Times
JULY 23, 2024
Differentiating between the 3 available options can help identify which is best for individual patients.
STAT
JULY 23, 2024
Amid concerns that the pharmaceutical industry abuses the U.S. patent system, a new paper suggests one way to crack down on the problem — amend a little-known method for correcting mistakes that lengthen the life of a patent and, consequently, can greatly add to the cost of medicines. The idea is to improve the way administrative delays are handled at the U.S.
Pharmacy Times
JULY 23, 2024
Vitamin C can improve levels of Nonheme Ferrous Fumarate or Ferrous Sulfate in the body
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
STAT
JULY 23, 2024
WASHINGTON — The Biden administration’s proposal to loosen federal restrictions on marijuana is dividing some of the nation’s top medical professionals. The nation’s largest and most powerful doctors group, the American Medical Association, has raised multiple concerns with the move, which is known as rescheduling. The American Psychiatric Association has said the drug should remain a Schedule I substance, like heroin and cocaine, one deemed to have no proven medical
Fierce Healthcare
JULY 23, 2024
Lawmakers bashed the business practices of pharmacy benefit managers during a House Committee on Oversight and Accountability hearing Tuesday. | A contentious hearing between PBM CEOs and the House Commitee on Oversight and Accountability reinforced recent federal angst toward pharmacy benefit managers, but little new ground was made.
STAT
JULY 23, 2024
When Sanjaya Singh left Johnson & Johnson in 2021, his former colleague Peter Lebowitz paid close attention. Singh had been a mainstay in the immunology and oncology fields, helping to invent the blockbuster drug Skyrizi and several other treatments during stints at Johnson & Johnson and Boehringer Ingelheim. “If Sanjaya Singh is doing something, you want to watch it,” Lebowitz said.
pharmaphorum
JULY 23, 2024
Former Welsh rugby union captain Alum Wyn Jones is the face of a new awareness campaign launching in the UK today to draw attention to atrial fibrillation (AF), an irregular and potentially life-threatening heart rhythm abnormality.
STAT
JULY 23, 2024
The Food and Drug Administration designates as “breakthrough” technologies certain drugs and devices. This designation helps expedite the development and review of therapies intended to treat serious conditions that may offer improvements over available therapies. Once breakthrough drugs and devices are approved, however, devices face a far less predictable pathway and a longer timeline to achieving reimbursement, including coverage by payers such as Medicare, compared to breakthro
pharmaphorum
JULY 23, 2024
Irina Spirieva, from Besins Healthcare, answers 12 intriguing questions about her journey in the healthcare industry. Learn more about her experiences and insights.
STAT
JULY 23, 2024
Veterans Affairs department officials said Monday they have launched a study to determine how removing race from widely used lung function tests may affect disability benefits for veterans, and they expect the impact to be much smaller than predicted in a study published earlier this year. They also said veterans who may have heard about the issue should not be concerned about any sudden changes to their benefits.
The Guardian - Pharmaceutical Industry
JULY 23, 2024
Generic version of a drug already on the market, which can suppress and prevent HIV, would still yield 30% profit if the current price was slashed, researchers say A new drug described as “the closest we have ever been to an HIV vaccine” could cost $40 (£31) a year for every patient, a thousand times less than its current price, new research suggests.
pharmaphorum
JULY 23, 2024
Agilent has boosted its contract development and manufacturing organisation (CDMO) capacity with a $925 million deal to buy Biovectra, a Canadian provider of fill-and-finish services and active pharmaceutical ingredients (APIs).It's a statement of intent from Agilent, whose primary business is lab instrumentation and equipment, suggesting that it intends to grow the outsourcing side of its business, which is currently focused on the production of oligonucleotide and peptide medicines.
Fierce Healthcare
JULY 23, 2024
Walgreens has received $25 million in grant funding to conduct a decentralized clinical trial assessing how well a person vaccinated against COVID-19 is protected from future infections. | The award comes from a consortium funded by the Biomedical Advanced Research and Development Authority (BARDA), embedded in the U.S. Department of Health & Human Services.
STAT
JULY 23, 2024
You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences. Sign up to get it delivered in your inbox every Tuesday and Thursday. Wastewater surveillance program sheds testing sites Sewage analysis has been in the spotlight recently as experts warn of an ongoing summer Covid surge.
Fierce Healthcare
JULY 23, 2024
By Laura Kohlhagen, MD, MBA, Chief Medical Officer for Sunrise™, Altera Digital Health | Many EHRs lack flexibility. So, what makes an EHR truly flexible, and how can greater flexibility get healthcare organizations where they want to go?
Pharmacy Times
JULY 23, 2024
The findings also demonstrate that body dysmorphic disorder is also associated with high levels of comorbid psychopathology, risk, and psychosocial impairment.
Fierce Healthcare
JULY 23, 2024
HCA Healthcare's stock jumped Tuesday morning as the hospital chain reported better-than-expected performance in the second quarter and boosted its 2024 guidance. | HCA Healthcare's stock jumped Tuesday morning as the hospital chain reported better-than-expected performance in the second quarter and boosted its 2024 guidance.
STAT
JULY 23, 2024
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. In an unfortunate twist of fate, an Oscar Mayer Weinermobile crashed into another vehicle and flipped on its side yesterday while driving around Chicago, famously known for its hot dogs. Thankfully, no injuries were reported.
Expert insights. Personalized for you.
528 
Let's personalize your content